Related references
Note: Only part of the references are listed.Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
An international randomized trial, comparing post-operative conformal radiotherapy (PORT) to no PORT, in patients with completely resected non-small cell lung cancer (NSCLC) and mediastinal N2 involvement: Primary end-point analysis of LungART (IFCT-0503, UK NCRI, SAKK) NCT00410683
C. Le Pechoux et al.
ANNALS OF ONCOLOGY (2020)
Targeted Therapies in Early Stage NSCLC: Hype or Hope?
Alex Friedlaender et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer
Yi-Long Wu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base
Amy C. Moreno et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Sequencing of Postoperative Radiotherapy and Chemotherapy for Locally Advanced or Incompletely Resected Non-Small-Cell Lung Cancer
Samual Francis et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database
Alex Herskovic et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Early postoperative radiotherapy is associated with improved outcomes over late postoperative radiotherapy in the management of completely resected (R0) Stage IIIA-N2 non-small cell lung cancer
Huan-Huan Wang et al.
ONCOTARGET (2017)
Radiation Therapy-First Strategy After Surgery With or Without Adjuvant Chemotherapy in Stage IIIA-N2 Non-Small Cell Lung Cancer
Hyun Woo Lee et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Cytotoxic Chemotherapy as First-Line Therapy for Advanced Non-Small-Cell Lung Cancer in Taiwan: Daily Practice
Yi-Hsin Liang et al.
JOURNAL OF CANCER (2016)
Comparative Effectiveness of First-Line Platinum-Based Chemotherapy Regimens for Advanced Lung Squamous Cell Carcinoma
Bin-Chi Liao et al.
CLINICAL LUNG CANCER (2015)
Quality assessment and improvement of nationwide cancer registration system in Taiwan: a review
Chun-Ju Chiang et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2015)
Postoperative Radiotherapy for Pathologic N2 Non-Small-Cell Lung Cancer Treated With Adjuvant Chemotherapy: A Review of the National Cancer Data Base
Cliff G. Robinson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Postoperative Radiotherapy is Associated with Better Survival in Non-Small Cell Lung Cancer with Involved N2 Lymph Nodes Results of an Analysis of the National Cancer Data Base
John L. Mikell et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Re-evaluation of the Role of Postoperative Radiotherapy and the Impact of Radiation Dose for Non-Small-Cell Lung Cancer Using the National Cancer Database
Christopher D. Corso et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
First-line pemetrexed plus cisplatin followed by gefitinib maintenance therapy versus gefitinib monotherapy in East Asian patients with locally advanced or metastatic non-squamous non-small cell lung cancer: A randomised, phase 3 trial
James Chih-Hsin Yang et al.
EUROPEAN JOURNAL OF CANCER (2014)
Efficacy and safety of pemetrexed/cisplatin versus gemcitabine/cisplatin as first-line treatment in Chinese patients with advanced nonsquamous non-small cell lung cancer
Yi-Long Wu et al.
LUNG CANCER (2014)
Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysis
Charlotte Billiet et al.
RADIOTHERAPY AND ONCOLOGY (2014)
Lymph Node Ratio May Predict the Benefit of Postoperative Radiotherapy in Non-Small-Cell Lung Cancer
Damien Urban et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
A closer look at the effects of postoperative radiotherapy by stage and nodal status: Updated results of an individual participant data meta-analysis in non-small-cell lung cancer
Sarah Burdett et al.
LUNG CANCER (2013)
Role of Postoperative Radiotherapy in Resected Non-Small Cell Lung Cancer: A Reassessment Based on New Data
Cecile Le Pechoux
ONCOLOGIST (2011)
Adjuvant Carboplatin-based Chemotherapy in Resected Stage IIIA-N2 Non-small Cell Lung Cancer
Wei Ou et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Impact of postoperative radiation therapy on survival in patients with complete resection and Stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: The Adjuvant Navelbine International Trialist Association (ANITA) randomized trial
Jean-Yves Douillard et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Lung Adjuvant Cisplatin Evaluation: A pooled analysis by the LACE collaborative group
Jean-Pierre Pignon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer
Giorgio Vittorio Scagliotti et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Estimating the magnitude and field-size dependence of radiotherapy-induced mortality and tumor control after postoperative radiotherapy for non-small-cell lung cancer: calculations from clinical trials
Edward F. Miles et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Trends in the use of postoperative radiotherapy for resected non-small-cell lung cancer
Justin E. Bekelman et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial
Jean-Yves Douillard et al.
LANCET ONCOLOGY (2006)
Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: A comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation
IS Grills et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Share Paper
